SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-013629
Filing Date
2022-04-07
Accepted
2022-04-07 17:20:28
Documents
13
Period of Report
2022-04-05
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10036203_8k.htm   iXBRL 8-K 28354
5 image0.jpg GRAPHIC 32875
  Complete submission text file 0001140361-22-013629.txt   247147

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cemi-20220405.xsd EX-101.SCH 3920
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cemi-20220405_lab.xml EX-101.LAB 22544
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cemi-20220405_pre.xml EX-101.PRE 16040
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10036203_8k_htm.xml XML 4052
Mailing Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788
Business Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788 (631) 924-1135
CHEMBIO DIAGNOSTICS, INC. (Filer) CIK: 0001092662 (see all company filings)

IRS No.: 880425691 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35569 | Film No.: 22814676
SIC: 2834 Pharmaceutical Preparations